Latest filing published 26 May 2009 for Molecular Insight Pharmaceuticals, Inc., €11k.
Insider track record
No signal scores available.
Donald E. Wallroth: trading record in brief
Donald E. Wallroth is a declared insider of Molecular Insight Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 20 May 2008 to 22 May 2009, the count stands at 3 filings.
Sales make up the whole of the open-market record (2 sales, €18k). Outside the open market, there are 1 share grant. So far in 2009, the count stands at no purchases and 2 sales.
The latest filing, published on 26 May 2009, reports an open-market sale of €11k in Molecular Insight Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Donald E. Wallroth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$3.80Common StockSEC:0001209191-09-028868:0
- 2,500 shares@ US$3.75Common StockSEC:0001209191-09-028868:1
- 20,000 shares@ US$0.01Common StockSEC:0001209191-08-032491:0
3 of 3 declarations
